DYN
NASDAQStockDyne Therapeutics, Inc.
$17.71-0.35 (-1.95%)
52-Week Range
$6.81
$24.29
Key Stats
Market Cap
2.9B
P/E Ratio
—
Dividend Yield
—
Beta
1.40
Volume
1.7M
Avg Volume
2.7M
Performance
1M
+12.87%
3M
-7.81%
6M
+40.44%
YTD
-2.38%
1Y
+49.88%
3Y
+42.99%
5Y
+7.69%
Price Chart
ETF Exposure
DYN is held by 110 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| MSGR | Direxion mRNA ETF | 3.05% |
| IBRN | iShares Neuroscience and Healthcare ETF | 2.82% |
| CURE.AX | Global X - S&P Biotech ETF | 0.92% |
| XBI | State Street SPDR S&P Biotech ETF | 0.92% |
| BBC | Virtus Biotech Clinical Trials ETF | 0.72% |
| JDOC | JPMorgan Healthcare Leaders ETF | 0.69% |
| MNTL | Tema Neuroscience And Mental Health ETF | 0.46% |
| SCDS | JPMorgan Fundamental Data Science Small Core ETF | 0.28% |
| OPTZ | Optimize Strategy Index ETF | 0.26% |
| SBIO.L | Invesco NASDAQ Biotech UCITS ETF | 0.22% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.22% |
| PQSG | PGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF | 0.22% |
| IBB | iShares Biotechnology ETF | 0.21% |
| LABU | Direxion Daily S&P Biotech Bull 3X ETF | 0.20% |
| PWS | Pacer WealthShield ETF | 0.16% |
| PQSV | PGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Value ETF | 0.15% |
| BBSC | JPMorgan BetaBuilders U.S. Small Cap Equity ETF | 0.14% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.14% |
| STXK | Strive Small-Cap ETF | 0.13% |
| IWN | iShares Russell 2000 Value ETF | 0.12% |
| RFLR | Innovator U.S. Small Cap Managed Floor ETF | 0.11% |
| TMSL | T. Rowe Price Small-Mid Cap ETF | 0.11% |
| BKSE | BNY Mellon US Small Cap Core Equity ETF | 0.11% |
| KBFR | Innovator U.S. Small Cap Managed 10 Buffer ETF | 0.11% |
| VTWV | Vanguard Russell 2000 Value ETF | 0.10% |
| TCAF | T. Rowe Price Capital Appreciation Equity ETF | 0.10% |
| ISCV | iShares Morningstar Small-Cap Value ETF | 0.09% |
| JKL | iShares Morningstar Small-Cap Value ETF | 0.09% |
| SC0K.DE | Invesco Russell 2000 UCITS ETF | 0.08% |
| IWM | iShares Russell 2000 ETF | 0.08% |
| XRS2.DE | Xtrackers Russell 2000 UCITS ETF 1C | 0.08% |
| XRSU.L | Xtrackers Russell 2000 UCITS ETF 1C | 0.08% |
| XSU.TO | iShares U.S. Small Cap Index ETF (CAD-Hedged) | 0.08% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.07% |
| VTWO | Vanguard Russell 2000 ETF | 0.07% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.07% |
| ESML | iShares ESG Aware MSCI USA Small-Cap ETF | 0.07% |
| R2SC.L | State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc) | 0.07% |
| RSSL | Global X - Russell 2000 ETF | 0.06% |
| UWM | ProShares - Ultra Russell2000 | 0.05% |
| IWO | iShares Russell 2000 Growth ETF | 0.05% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.05% |
| NUSC | Nuveen ESG Small-Cap | 0.05% |
| ISCB | iShares Morningstar Small-Cap ETF | 0.05% |
| JKJ | iShares Morningstar Small-Cap ETF | 0.05% |
| URTY | ProShares - UltraPro Russell2000 | 0.04% |
| VTWG | Vanguard Russell 2000 Growth ETF | 0.04% |
| FHLC | FIDELITY MSCI HEALTH CARE INDEX ETF | 0.04% |
| VXF | Vanguard Extended Market ETF | 0.03% |
| DFAS | Dimensional - US Small Cap ETF | 0.03% |
Page 1 of 3Next
About DYN ETF Exposure
Dyne Therapeutics, Inc. (DYN) is held by 110 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 2.9B, DYN is a widely held institutional stock. The stock currently trades at $17.71. Investors can gain exposure to DYN through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold DYN, sorted by portfolio weight.